vs

Side-by-side financial comparison of BNY Mellon (BK) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

BNY Mellon is the larger business by last-quarter revenue ($1.3B vs $719.4M, roughly 1.9× Healthpeak Properties). BNY Mellon runs the higher net margin — 108.5% vs 73.2%, a 35.4% gap on every dollar of revenue. On growth, BNY Mellon posted the faster year-over-year revenue change (12.7% vs 3.1%). BNY Mellon produced more free cash flow last quarter ($4.7B vs $357.0M). Over the past eight quarters, BNY Mellon's revenue compounded faster (13.8% CAGR vs 8.9%).

The Bank of New York Mellon Corporation, commonly known as BNY or by its prior brand name BNY Mellon, is an American international financial services company headquartered in New York City. It was established in its current form in July 2007 by the merger of the Bank of New York and Mellon Financial Corporation.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

BK vs DOC — Head-to-Head

Bigger by revenue
BK
BK
1.9× larger
BK
$1.3B
$719.4M
DOC
Growing faster (revenue YoY)
BK
BK
+9.7% gap
BK
12.7%
3.1%
DOC
Higher net margin
BK
BK
35.4% more per $
BK
108.5%
73.2%
DOC
More free cash flow
BK
BK
$4.4B more FCF
BK
$4.7B
$357.0M
DOC
Faster 2-yr revenue CAGR
BK
BK
Annualised
BK
13.8%
8.9%
DOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BK
BK
DOC
DOC
Revenue
$1.3B
$719.4M
Net Profit
$1.5B
$114.0M
Gross Margin
Operating Margin
17.4%
Net Margin
108.5%
73.2%
Revenue YoY
12.7%
3.1%
Net Profit YoY
26.5%
2406.4%
EPS (diluted)
$2.01
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BK
BK
DOC
DOC
Q4 25
$1.3B
$719.4M
Q3 25
$1.2B
$705.9M
Q2 25
$1.2B
$694.3M
Q1 25
$1.2B
$702.9M
Q4 24
$1.2B
$698.0M
Q3 24
$1.0B
$700.4M
Q2 24
$1.0B
$695.5M
Q1 24
$1.0B
$606.6M
Net Profit
BK
BK
DOC
DOC
Q4 25
$1.5B
$114.0M
Q3 25
$1.4B
$-117.1M
Q2 25
$1.4B
$31.7M
Q1 25
$1.2B
$42.8M
Q4 24
$1.2B
$4.5M
Q3 24
$1.2B
$85.9M
Q2 24
$1.2B
$146.0M
Q1 24
$1.0B
$6.7M
Gross Margin
BK
BK
DOC
DOC
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Q1 24
59.8%
Operating Margin
BK
BK
DOC
DOC
Q4 25
17.4%
Q3 25
9.2%
Q2 25
5.7%
Q1 25
7.7%
Q4 24
-2.2%
Q3 24
14.1%
Q2 24
22.3%
Q1 24
3.7%
Net Margin
BK
BK
DOC
DOC
Q4 25
108.5%
73.2%
Q3 25
116.9%
-16.6%
Q2 25
118.3%
4.6%
Q1 25
105.3%
6.1%
Q4 24
96.7%
0.7%
Q3 24
112.8%
12.3%
Q2 24
113.4%
21.0%
Q1 24
98.6%
1.1%
EPS (diluted)
BK
BK
DOC
DOC
Q4 25
$2.01
$0.16
Q3 25
$1.88
$-0.17
Q2 25
$1.93
$0.05
Q1 25
$1.58
$0.06
Q4 24
$1.53
$0.02
Q3 24
$1.50
$0.12
Q2 24
$1.52
$0.21
Q1 24
$1.25
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BK
BK
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$5.1B
$467.5M
Total DebtLower is stronger
$31.9B
$9.8B
Stockholders' EquityBook value
$44.3B
$7.5B
Total Assets
$472.3B
$20.3B
Debt / EquityLower = less leverage
0.72×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BK
BK
DOC
DOC
Q4 25
$5.1B
$467.5M
Q3 25
$5.1B
$91.0M
Q2 25
$5.7B
$89.4M
Q1 25
$5.4B
$70.6M
Q4 24
$4.2B
$119.8M
Q3 24
$6.2B
$180.4M
Q2 24
$5.3B
$106.9M
Q1 24
$5.3B
$101.8M
Total Debt
BK
BK
DOC
DOC
Q4 25
$31.9B
$9.8B
Q3 25
$32.3B
$9.1B
Q2 25
$33.4B
$9.0B
Q1 25
$30.9B
$8.9B
Q4 24
$30.9B
$8.7B
Q3 24
$33.2B
$8.6B
Q2 24
$30.9B
$8.6B
Q1 24
$32.4B
$8.8B
Stockholders' Equity
BK
BK
DOC
DOC
Q4 25
$44.3B
$7.5B
Q3 25
$43.9B
$7.6B
Q2 25
$44.0B
$7.9B
Q1 25
$43.1B
$8.2B
Q4 24
$41.3B
$8.4B
Q3 24
$42.0B
$8.6B
Q2 24
$40.8B
$8.8B
Q1 24
$40.6B
$8.9B
Total Assets
BK
BK
DOC
DOC
Q4 25
$472.3B
$20.3B
Q3 25
$455.3B
$19.6B
Q2 25
$485.8B
$19.8B
Q1 25
$440.7B
$19.8B
Q4 24
$416.1B
$19.9B
Q3 24
$427.5B
$20.0B
Q2 24
$428.5B
$20.2B
Q1 24
$434.7B
$20.5B
Debt / Equity
BK
BK
DOC
DOC
Q4 25
0.72×
1.31×
Q3 25
0.74×
1.20×
Q2 25
0.76×
1.14×
Q1 25
0.72×
1.08×
Q4 24
0.75×
1.04×
Q3 24
0.79×
1.00×
Q2 24
0.76×
0.98×
Q1 24
0.80×
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BK
BK
DOC
DOC
Operating Cash FlowLast quarter
$5.2B
$1.3B
Free Cash FlowOCF − Capex
$4.7B
$357.0M
FCF MarginFCF / Revenue
352.8%
49.6%
Capex IntensityCapex / Revenue
32.4%
124.4%
Cash ConversionOCF / Net Profit
3.55×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$5.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BK
BK
DOC
DOC
Q4 25
$5.2B
$1.3B
Q3 25
$-1.1B
$315.0M
Q2 25
$2.2B
$363.5M
Q1 25
$412.0M
$279.4M
Q4 24
$1.6B
$1.1B
Q3 24
$-312.0M
$318.2M
Q2 24
$2.1B
$316.2M
Q1 24
$-2.7B
$152.6M
Free Cash Flow
BK
BK
DOC
DOC
Q4 25
$4.7B
$357.0M
Q3 25
$-1.5B
Q2 25
$1.8B
Q1 25
$92.0M
Q4 24
$1.1B
$333.7M
Q3 24
$-687.0M
Q2 24
$1.7B
Q1 24
$-3.0B
FCF Margin
BK
BK
DOC
DOC
Q4 25
352.8%
49.6%
Q3 25
-121.5%
Q2 25
152.8%
Q1 25
7.9%
Q4 24
95.2%
47.8%
Q3 24
-65.6%
Q2 24
169.6%
Q1 24
-286.4%
Capex Intensity
BK
BK
DOC
DOC
Q4 25
32.4%
124.4%
Q3 25
35.4%
Q2 25
29.8%
Q1 25
27.6%
Q4 24
34.6%
105.6%
Q3 24
35.8%
Q2 24
37.1%
Q1 24
28.7%
Cash Conversion
BK
BK
DOC
DOC
Q4 25
3.55×
10.99×
Q3 25
-0.74×
Q2 25
1.54×
11.48×
Q1 25
0.34×
6.52×
Q4 24
1.34×
235.43×
Q3 24
-0.26×
3.71×
Q2 24
1.82×
2.17×
Q1 24
-2.61×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons